Neurodegen (broad)
0 causal edges 7 causal effects 12 hypotheses 0 open gaps 8 papers
Causal-edge map (sample)
Explore in Knowledge Graph →Inner ring = highest depth_score (out-edges − in-edges). Outer ring = next-most-upstream. Edge thickness = claimed confidence.
Top causal effects
Quantitative effect-size rows from substrate_causal_effects (Q-CAUSAL Phase 1). Sorted by |effect_size| desc.
- mechanism epigenetic silencing → disease neurodegeneration — p n/a LLM_inferred
- process Glucose Metabolic Reprogramming → disease Neurodegeneration — p n/a LLM_inferred
- mechanism proteostasis failure → disease neurodegeneration — p n/a LLM_inferred
- mechanism microglial senescence → disease neurodegeneration vulnerability — p n/a LLM_inferred
- mechanism energy metabolism disorders → disease Parkinson's disease-like neurodegeneration — p n/a LLM_inferred
- mechanism vesicular transport disruption → disease neurodegeneration vulnerability — p n/a LLM_inferred
- mechanism APOE4 removal → mechanism tau-mediated neurodegeneration protection — p n/a LLM_inferred
Upstream-target candidates
Ranked by depth_score = out-edges − in-edges. High score = strong upstream signal.
- mechanism:APOE4 removal +1 0 mentions
- mechanism:TFEB overexpression +1 0 mentions
- mechanism:epigenetic silencing +1 0 mentions
- mechanism:vesicular transport disruption +1 0 mentions
- process:Glucose Metabolic Reprogramming +1 0 mentions
- mechanism:energy metabolism disorders 0 0 mentions
- mechanism:microglial senescence 0 0 mentions
- mechanism:proteostasis failure 0 0 mentions
Leading hypotheses
- Astrocyte GAT-3 dysfunction and inhibitory-network disruption in ALS/FTD
- TREM2-dependent microglial lipid handling in Alzheimer's disease
- ER-mitochondria contact-site dysfunction in neurodegeneration
- TDP-43 phase-separation and nuclear-function failure in ALS/FTD
- USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's Disease
- PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease
- Glial Metabolic Coupling Failure in Neuronal Bioenergetic Crisis
- Lysosomal GBA1 Enhancement via Glucosylceramide Reduction
- Complement C1q/C3 Blockade for Alzheimer's Disease
- circRNA dysregulation as neurodegeneration biomarker and exploratory therapeutic biology
- Glial Progenitor Cell Support in Huntington's Disease
- OPC exhaustion and failed remyelination in progressive multiple sclerosis